These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9531963)

  • 1. Lung hypoplasia--a possible teratogenic effect of valproate. Case report.
    Janas MS; Arrøe M; Hansen SH; Graem N
    APMIS; 1998 Feb; 106(2):300-4. PubMed ID: 9531963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal valproate syndrome.
    Kulkarni ML; Zaheeruddin M; Shenoy N; Vani HN
    Indian J Pediatr; 2006 Oct; 73(10):937-9. PubMed ID: 17090909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple congenital malformations including generalized hypertrichosis with gum hypertrophy in a child exposed to valproic acid in utero.
    Stoll C; Audeoud F; Gaugler C; Bernardin A; Messer J
    Genet Couns; 2003; 14(3):289-98. PubMed ID: 14577673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Middle and inner ear malformations in two siblings exposed to valproic acid during pregnancy: a case report.
    Van Houtte E; Casselman J; Janssens S; De Kegel A; Maes L; Dhooge I
    Int J Pediatr Otorhinolaryngol; 2014 Nov; 78(11):2007-10. PubMed ID: 25216807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
    Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced corneal sensation and severe dry eyes in a child with fetal valproate syndrome.
    Boyle NJ; Clarke MP; Figueiredo F
    Eye (Lond); 2001 Oct; 15(Pt 5):661-2. PubMed ID: 11702984
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metopic suture craniosynostosis: sodium valproate teratogenic effect. Case report].
    Assencio-Ferreira VJ; Abraham R; Veiga JC; Santos KC
    Arq Neuropsiquiatr; 2001 Jun; 59(2-B):417-20. PubMed ID: 11460190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Embryofetopathy due to valproate: a pathology only little known. Apropos of 4 cases].
    Espinasse M; Manouvrier S; Boute O; Farriaux JP
    Arch Pediatr; 1996 Sep; 3(9):896-9. PubMed ID: 8949354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.
    Thisted E; Ebbesen F
    Arch Dis Child; 1993 Sep; 69(3 Spec No):288-91. PubMed ID: 8215567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omphalocele in a newborn baby exposed to sodium valproate in utero.
    Boussemart T; Bonneau D; Levard G; Berthier M; Oriot D
    Eur J Pediatr; 1995 Mar; 154(3):220-1. PubMed ID: 7758521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fetal valproate syndrome].
    Sonoda T
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):96-8. PubMed ID: 11057157
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment: valproate dose effects differ across congenital malformations.
    Meador KJ
    Neurology; 2013 Sep; 81(11):1002. PubMed ID: 23911754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A male with fetal valproate syndrome and autism.
    Williams PG; Hersh JH
    Dev Med Child Neurol; 1997 Sep; 39(9):632-4. PubMed ID: 9344057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate and the risk for congenital malformations: Is formulation and dosage regime important?
    Mawhinney E; Campbell J; Craig J; Russell A; Smithson W; Parsons L; Robertson I; Irwin B; Morrison P; Liggan B; Delanty N; Hunt S; Morrow J
    Seizure; 2012 Apr; 21(3):215-8. PubMed ID: 22364656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate.
    Ebbesen F; Joergensen A; Hoseth E; Kaad PH; Moeller M; Holsteen V; Rix M
    Arch Dis Child Fetal Neonatal Ed; 2000 Sep; 83(2):F124-9. PubMed ID: 10952707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to valproate and risk of congenital malformations-Could we have known earlier?-A population-based cohort study.
    Christensen J; Trabjerg BB; Sun Y; Gilhus NE; Bjørk MH; Tomson T; Dreier JW
    Epilepsia; 2021 Dec; 62(12):2981-2993. PubMed ID: 34585373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of fetal valproate syndrome with intractable wheezing due to submucosal tumor below the vocal cord].
    Adachi M; Ai Y; Maeda E
    No To Hattatsu; 1999 Nov; 31(6):553-7. PubMed ID: 10565194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Embryopathy due to valproic acid with severe malformations in the central nervous system].
    Pardal-Fernández JM; Carrascosa-Romero MC; Rodríguez-Vázquez M; Marco-Giner J; Martínez-Gutiérrez A
    Rev Neurol; 2006 Mar 16-31; 42(6):336-40. PubMed ID: 16575769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
    Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A girl with foetal valproate syndrome and autism spectrum disorder].
    Solignac I
    Tijdschr Psychiatr; 2016; 58(3):228-31. PubMed ID: 26979855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.